Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 3/20 | 0.57 |
| ▸ | GSR | P00390 | 2/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.46 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.42 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.39 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15710641 | 0.97 | GABRR1 (0.55) | GABRR1GSRENPEPRNPEPCPB2 | |
| SCHEMBL18342682 | 0.85 | GABRR1 (0.50) | GABRR1GSRENPEPRNPEPCPB2 | |
| SCHEMBL8166138 | 0.83 | GABRR1 (0.54) | GABRR1GSRENPEPRNPEPCPB2 | |
| SCHEMBL5813280 | 0.83 | GABRR1 (0.54) | GABRR1GSRENPEPRNPEPCPB2 | |
| SCHEMBL8125795 | 0.83 | GABRR1 (0.48) | GABRR1GSRENPEPRNPEPCPB2 | |
| SCHEMBL15710597 | 0.81 | CPB2 (0.56) | GABRR1GSRENPEPRNPEPCPB2 | |
| Hydrochloric Acid SCHEMBL7364749 | 0.81 | GABRR1 (0.52) | GABRR1GSRENPEPRNPEPCPB2 | |
| SCHEMBL1938544 | 0.81 | GABRR1 (0.46) | GABRR1GSRENPEPRNPEPCPB2 | |
| SCHEMBL1807063 | 0.79 | GSR (0.65) | GABRR1GSRENPEPRNPEPCPB2 | |
| SCHEMBL15710827 | 0.79 | CPB2 (0.54) | GABRR1GSRENPEPRNPEPCPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2920249-B1 | SELF-DISPERSING PIGMENTS | CHEMOURS CO FC LLC (US) | 2020-04-01 | — | — | EP | claimed |
| US-10316209-B2 | Self-dispersing pigments | THE CHEMOURS COMPANY FC, LLC (US) | 2019-06-11 | — | — | US | claimed |
| EP-2920361-B1 | DÉCOR PAPER COMPRISING SELF-DISPERSING PIGMENTS | CHEMOURS CO FC LLC (US) | 2018-06-27 | — | — | EP | claimed |
| EP-2740738-B1 | PLATINUM COMPOUNDS FOR TREATING CELL PROLIFERATIVE DISEASE, PREPARATION METHODS AND USES THEREOF | BEIJING FSWELCOME TECH DEVELOPMENT CO LTD (CN) | 2018-03-28 | — | — | EP | claimed |
| CN-104937040-B | Self-dispersing pigment | 纳幕尔杜邦公司 | 2017-11-21 | — | — | CN | claimed |
| CN-104937041-B | Method for preparing self-dispersing pigment | 纳幕尔杜邦公司 | 2017-10-27 | — | — | CN | claimed |
| CN-104919007-B | Self-dispersing pigments comprising silica | 纳幕尔杜邦公司 | 2017-09-26 | — | — | CN | claimed |
| CN-104919009-B | The lamilate as made from the facing paper comprising self-dispersing pigment | 纳幕尔杜邦公司 | 2017-08-29 | — | — | CN | claimed |
| CN-104937167-B | Include the facing paper of self-dispersing pigment | 纳幕尔杜邦公司 | 2017-08-08 | — | — | CN | claimed |
| CN-104936780-B | The lamilate prepared by the facing paper comprising self-dispersing pigment | 纳幕尔杜邦公司 | 2017-07-18 | — | — | CN | claimed |
| WO-2014078048-A1 | DÉCOR PAPER COMPRISING SELF-DISPERSING PIGMENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | WO | claimed |
| WO-2014078040-A1 | PROCESS FOR PREPARING SELF-DISPERSING PIGMENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | WO | claimed |
| WO-2014078044-A1 | SILICA CONTAINING SELF-DISPERSING PIGMENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | WO | claimed |
| US-20140142079-A1 | PLATINUM COMPOUNDS FOR TREATING CELL PROLIFERATIVE DISEASES, PREPARATION METHOD AND USE THEREOF | BEIJING FSWELCOME TECHNOLOGY DEVELOPMENT CO., LTD. (CN) | 2014-05-22 | — | — | US | claimed |
| WO-2014078046-A1 | PROCESS FOR MAKING SILICA CONTAINING SELF-DISPERSING PIGMENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | WO | claimed |
| WO-2014078043-A1 | LAMINATES PREPARED FROM DÉCOR PAPER COMPRISING SELF-DISPERSING PIGMENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | WO | claimed |
| WO-2014078050-A1 | LAMINATES PREPARED FROM DÉCOR PAPER COMPRISING SELF-DISPERSING PIGMENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | WO | claimed |
| WO-2014078041-A1 | DÉCOR PAPER COMPRISING SELF-DISPERSING PIGMENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | WO | claimed |
| EP-2280696-A1 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2011-02-09 | — | — | EP | claimed |
| WO-2009117095-A1 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2009-09-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142079-A1 | PLATINUM COMPOUNDS FOR TREATING CELL PROLIFERATIVE DISEASES, PREPARATION METHOD AND USE THEREOF | PCNA, POLI, MKI67 | GABRR1 4168/4885GSR 810/4885ENPEP 441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.